“…In more detail, pemphigus vulgaris, an ASBD with Dsg 3 as the target antigen (Amagai et al, 1991), was found to be associated with HLA-DRW4 in a Jewish cohort, with HLA-DQw1 and -DQw3 polymorphisms in Ashkenazi Jews, HLA-DRB1*04 and DRB1*1401 in Iranian patients, HLA-DRB1*0402 haplotypes in Venezuelan patients, HLA-DQB1*0503, -B*1507 or -DRB1*1405 in Japanese patients, as well as HLA-B38 and HLA-Bw55 in an American cohort (Park et al, 1979;Szafer et al, 1987;Miyagawa et al, 1999Miyagawa et al, , 2002Lee et al, 2006;Saenz-Cantele et al, 2007;Shams et al, 2009). For bullous pemphigoid (BP), an ASBD with antibodies directed against hemidesmosomal proteins termed BP180 (type XVII collagen, COL17) and BP230 (Stanley et al, 1981(Stanley et al, , 1988Diaz et al, 1990), major histocompatibility complex (MHC) association studies have also not been conclusive (Delgado et al, 1996;Okazaki et al, 2000). In 29 patients with epidermolysis bullosa acquisita (EBA) and 5 patients with bullous lupus erythematodes, an association with HLA-DR2 has been described (Gammon et al, 1988).…”